Evaluating the TUITEK^® patient support program in supporting caregivers of children diagnosed with growth hormone deficiency in Argentina.

ABSTRACT:

Introduction

The appropriate use of recombinant human growth hormone (r-hGH) treatment provides an opportunity to improve growth outcomes among pediatric patients with growth hormone deficiency (GHD). However, a major challenge in clinical practice is to adequately recognize and address factors that negatively affect treatment adherence. TUITEK^® patient support program (PSP) was designed to help caregivers of children diagnosed with GHD to personalize the care pathway, improve adherence, and achieve better outcomes. Effectiveness of TUITEK^® PSP has been demonstrated previously in a smaller sample (n = 31) in Taiwanese population. Here, we present the results from Argentina.

Methods

TUITEK^® PSP was piloted among 76 caregivers of children with

SUBMITTER: Assefi AR 

PROVIDER: S-EPMC10117813 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature